Announcements Trials
Browse Landscape

Phase

Phase 1 2

Status

Completed 2

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other solid neoplasm 2Thoracic 1

Conditions

Advanced Solid Tumors 2

Interventions

Cisplatin 147pembrolizumab 129Carboplatin 126Injections 108Pemetrexed 99Paclitaxel 97Gemcitabine 85Irinotecan 75Cyclophosphamide 72Nivolumab 71Docetaxel 68Bevacizumab 59Oxaliplatin 50Fluorouracil 50Capecitabine 48atezolizumab 46Leucovorin 42Etoposide 42tislelizumab 40toripalimab 36fludarabine 32Drug Therapy 32Ipilimumab 30Topotecan 29durvalumab 28Vincristine 27Specimen Handling 27Early Intervention, Educational 27Radiotherapy 26Interviews as Topic 26

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
TAS-114 × Other solid neoplasm × Clear all
NCT02454062 2024-09-04

A Trial of TAS-114 in Combination With S-1

Taiho Oncology, Inc.

Phase 1 Completed
120 enrolled
Other solid neoplasm

Advanced Solid Tumors

NCT01610479 2017-08-04

A Study of TAS-114 in Combination With S-1 in Patients With Advanced Solid Tumors

Taiho Pharmaceutical Co., Ltd.

Phase 1 Completed
120 enrolled
Other solid neoplasm

Advanced Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡